We noted varying mutation profiles of the circadian genes across the 14 tested breast cancer cell lines, with the majority of cell models exhibiting at least one mutation, whereas five cell lines showed no mutations in their circadian clock network (Fig. 3D). The gene discussed is CLOCK; the disease is breast carcinoma.